In an in vitro study, ceftaroline plus amikacin was synergistic against 90% of isolates tested, including Pseudomonas aeruginosa , extended-spectrum ??- lactamase (ESBL)-producing Escherichia coli , ESBL-producing Klebsiella pneumoniae and AmpC-derepressed Enterobacter cloacae .